38075821|t|Amyloid beta,alpha-Synuclein and Amyloid beta-alpha-Synuclein Combination Exert Significant but Different Alterations in Inflammatory Response Profile in Differentiated Human SH-SY5Y Cells.
38075821|a|Neurodegeneration is a condition in which the neuronal structure and functions are altered with reduced neuronal survival and increased neuronal death in the central nervous system (CNS). Amyloid-beta (Abeta) is the pathological hallmark of a common neurodegenerative disorder, Alzheimer disease. Parkinson disease and dementia with Lewy bodies are among alpha-synucleinopathies characterized by abnormal accumulation of insoluble alpha-synuclein protein. Neuroinflammation is seen in those neurodegenerative disorders regulated by cytokines and chemokines released from neurons, microglia, and astrocytes. Our study aimed to (1) define steady-state levels of cytokines and immune response modulators in SH-SY5Y cells that were differentiated into neuron-like cells and (2) compare the levels of target cytokines in cellular models of neurodegenerative disorders, namely, AD, PD, and DLB-like pathologies. AD, PD, and DLB-like pathologies were established by 6 muM Abeta1-42 administration, SNCA (alpha-synuclein) overexpression, and SNCA overexpression was followed by Abeta1-42 treatment, respectively. Alterations in the levels of 40 released inflammatory proteins (IPs) were analyzed by chemiluminescence-based Western/dot blot. Overexpression of human alpha-synuclein and administration of Abeta1-42 significantly changed the profile of IPs secretion, with particularly significant changes in CSF2, CCL5, CXCL8, CXCL10, ICAM1, IL1B, and IL16. Bioinformatics analysis revealed possible interactions between alpha-synuclein and IL1B. While TGF1, CCL2, TNF, IL10, IL4, and IL1B IPs were associated with Abeta 1-42, Abeta 1-42 treatment together with alpha-synuclein, overexpression is associated only with the IL6 protein. Consequently, AD, PD, and DLB-like pathologies might exert significant but different alterations in the inflammatory response.
38075821	0	12	Amyloid beta	Gene	351
38075821	13	28	alpha-Synuclein	Gene	6622
38075821	121	133	Inflammatory	Disease	MESH:D007249
38075821	169	174	Human	Species	9606
38075821	175	182	SH-SY5Y	CellLine	CVCL:0019
38075821	190	207	Neurodegeneration	Disease	MESH:D019636
38075821	326	340	neuronal death	Disease	MESH:D009410
38075821	378	390	Amyloid-beta	Gene	351
38075821	392	397	Abeta	Gene	351
38075821	440	466	neurodegenerative disorder	Disease	MESH:D019636
38075821	468	485	Alzheimer disease	Disease	MESH:D000544
38075821	487	504	Parkinson disease	Disease	MESH:D010300
38075821	509	534	dementia with Lewy bodies	Disease	MESH:D020961
38075821	545	568	alpha-synucleinopathies	Disease	MESH:D000080874
38075821	621	636	alpha-synuclein	Gene	6622
38075821	646	663	Neuroinflammation	Disease	MESH:D000090862
38075821	681	708	neurodegenerative disorders	Disease	MESH:D019636
38075821	894	901	SH-SY5Y	CellLine	CVCL:0019
38075821	1025	1052	neurodegenerative disorders	Disease	MESH:D019636
38075821	1062	1064	AD	Disease	MESH:D000544
38075821	1066	1068	PD	Disease	MESH:D010300
38075821	1074	1077	DLB	Disease	MESH:D020961
38075821	1096	1098	AD	Disease	MESH:D000544
38075821	1100	1102	PD	Disease	MESH:D010300
38075821	1108	1111	DLB	Disease	MESH:D020961
38075821	1181	1185	SNCA	Gene	6622
38075821	1187	1202	alpha-synuclein	Gene	6622
38075821	1224	1228	SNCA	Gene	6622
38075821	1336	1357	inflammatory proteins	Disease	MESH:D007249
38075821	1359	1362	IPs	Disease	MESH:D007249
38075821	1441	1446	human	Species	9606
38075821	1447	1462	alpha-synuclein	Gene	6622
38075821	1532	1535	IPs	Disease	MESH:D007249
38075821	1588	1592	CSF2	Gene	1437
38075821	1594	1598	CCL5	Gene	6352
38075821	1600	1605	CXCL8	Gene	3576
38075821	1607	1613	CXCL10	Gene	3627
38075821	1615	1620	ICAM1	Gene	3383
38075821	1622	1626	IL1B	Gene	3553
38075821	1632	1636	IL16	Gene	3603
38075821	1701	1716	alpha-synuclein	Gene	6622
38075821	1721	1726	IL1B.	Gene	3553
38075821	1739	1743	CCL2	Gene	6347
38075821	1745	1748	TNF	Gene	7124
38075821	1750	1754	IL10	Gene	3586
38075821	1756	1759	IL4	Gene	3565
38075821	1765	1769	IL1B	Gene	3553
38075821	1770	1773	IPs	Disease	MESH:D007249
38075821	1842	1857	alpha-synuclein	Gene	6622
38075821	1902	1905	IL6	Gene	3569
38075821	1929	1931	AD	Disease	MESH:D000544
38075821	1933	1935	PD	Disease	MESH:D010300
38075821	1941	1944	DLB	Disease	MESH:D020961
38075821	2019	2031	inflammatory	Disease	MESH:D007249
38075821	Association	MESH:D007249	3576
38075821	Association	3627	6622
38075821	Association	MESH:D019636	351
38075821	Association	MESH:D010300	6622
38075821	Association	3383	6622
38075821	Association	MESH:D020961	6622
38075821	Association	MESH:D007249	3586
38075821	Association	MESH:D007249	6622
38075821	Association	3576	6622
38075821	Association	MESH:D000544	351
38075821	Association	MESH:D007249	3627
38075821	Association	3553	6622
38075821	Association	MESH:D007249	1437
38075821	Association	1437	6622
38075821	Association	MESH:D007249	3553
38075821	Association	MESH:D007249	351
38075821	Association	MESH:D007249	3383
38075821	Association	MESH:D007249	3603
38075821	Association	MESH:D000544	6622
38075821	Association	3603	6622
38075821	Association	MESH:D007249	6352
38075821	Association	3569	6622
38075821	Association	6352	6622

